I agree that this site is using cookies. You can find further informations here.
X
Kabeya, Kabamba
55  results:
Search for persons X
?
1

Limited HIV-1 Reactivation in Resting CD4+ T cells from Avi..:

Kumar, Amit ; Abbas, Wasim ; Bouchat, Sophie...
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
?
2

Tuning of AKT-pathway by Nef and its blockade by protease i..:

Kumar, Amit ; Abbas, Wasim ; Colin, Laurence...
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
?
3

Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women:

Colbers, Angela ; Best, Brookie ; Schalkwijk, Stein...
Clinical Infectious Diseases.  61 (2015)  10 - p. 1582-1589 , 2015
Link: https://doi.org/10.1093/..
 
?
4

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacet..:

Bouchat, Sophie ; Delacourt, Nadège ; Kula, Anna...
EMBO Molecular Medicine.  8 (2015)  2 - p. 117-138 , 2015
Link: https://doi.org/10.15252..
 
?
5

Comparison of Methods for In-House Screening of HLA-B*57:01..:

De Spiegelaere, Ward ; Philippé, Jan ; Vervisch, Karen...
PLOS ONE.  10 (2015)  4 - p. e0123525 , 2015
Link: https://doi.org/10.1371/..
 
?
6

Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinet..:

Blonk, Maren I. ; Colbers, Angela P. H. ; Hidalgo-Tenorio, Carmen...
Clinical Infectious Diseases.  61 (2015)  5 - p. 809-816 , 2015
Link: https://www.jstor.org/st..
 
?
7

Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women:

Colbers, Angela ; Best, Brookie ; Schalkwijk, Stein...
Clinical Infectious Diseases.  61 (2015)  10 - p. 1582-1589 , 2015
Link: https://www.jstor.org/st..
 
?
8

An In-Depth Comparison of Latency-Reversing Agent Combinati..:

Darcis, Gilles ; Kula, Anna ; Bouchat, Sophie...
PLOS Pathogens.  11 (2015)  7 - p. e1005063 , 2015
Link: https://doi.org/10.1371/..
 
?
9

Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinet..:

Blonk, Maren I. ; Colbers, Angela P. H. ; Hidalgo-Tenorio, Carmen...
Clinical Infectious Diseases.  61 (2015)  5 - p. 809-816 , 2015
Link: https://doi.org/10.1093/..
 
?
10

Pharmacokinetics of total and unbound darunavir in HIV-1-in..:

Colbers, Angela ; Moltó, José ; Ivanovic, Jelena...
Journal of Antimicrobial Chemotherapy.  70 (2014)  2 - p. 534-542 , 2014
Link: https://doi.org/10.1093/..
 
?
11

First-line therapy with LPV/r vs NVP and 2 NRTIs in a devel..:

Clumeck, Nathan ; Mwamba, Claude ; Kabeya, Kabamba...
BMC Infectious Diseases.  14 (2014)  S2 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
12

The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirti..:

Covens, Kris ; Megens, Sarah ; Dekeersmaeker, Nathalie...
Antiviral Research.  86 (2010)  3 - p. 253-260 , 2010
Link: https://doi.org/10.1016/..
 
?
13

HIV-1 V3 envelope deep sequencing for clinical plasma speci..:

Vandenbroucke, Ina ; Van Marck, Herwig ; Mostmans, Wendy...
AIDS Research and Therapy.  7 (2010)  1 - p. , 2010
Link: https://doi.org/10.1186/..
 
?
14

Evolution of genotypic resistance to enfuvirtide in HIV-1 i..:

Covens, Kris ; Kabeya, Kabamba ; Schrooten, Yoeri...
Journal of Clinical Virology.  44 (2009)  4 - p. 325-328 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Synergistic Activation of HIV-1 Expression by Deacetylase I..:

Reuse, Sophie ; Calao, Miriam ; Kabeya, Kabamba...
PLoS ONE.  4 (2009)  6 - p. e6093 , 2009
Link: https://doi.org/10.1371/..
 
1-15